Watch Ticker

MiMedx Group, Inc

Go to MiMedx Group, Inc Website

$6.97

-0.18 (-2.52%)

Live

Previous Close

$7.15

Day Range

$6.965 - $7.2

Previous Day Range

$7.085 - $7.44

Market Cap

$1.1 billion USD

Day Vol.

906077

Previous Day Vol.

980650

Currency

USD

Primary Exchange

Nasdaq

MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, an...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

N/A - MediWound Initiates the VALUE Global Phase III Pivotal Trial of EscharEx® for Treatment of Venous Leg Ulcers

MediWound has initiated a global Phase III trial to evaluate the efficacy and safety of its wound debridement therapy EscharEx for the treatment of venous leg ulcers. The trial aims to assess EscharEx's ability to effectively debride chronic wounds and prepare the wound bed for healing.

Related tickers: MDWD, SOLV, MDXG.

Read Full Article

Globe Newswire - Chronic Wound Care Market to Expand at a Modest 4.17% CAGR through 2031 | SkyQuest Technology

The chronic wound care market is expected to grow at a CAGR of 4.17% from 2024 to 2031, driven by the high prevalence of chronic diseases and advancements in wound care technologies. The market is segmented by product, application, end-user, and region, with North America leading due to its developed healthcare infrastructure.

Related tickers: JNJ, BAX, MMM, CNVVY, IART, SNN, CAH, MDXG, CLPBY.

Read Full Article

Trending Tickers

Please sign in to view